Lumeva · MIG · Spain · General neurologist · captured by Fatima Al-Sayed on 08 Sept 2026 · reviewed by Dr. Elena Moretti on 09 Sept 2026
Verbatim as captured; never edited
Fourteen inquiries in the last 60 days ask whether a washout is needed when switching from an anti-CGRP monoclonal antibody to lumevarin. No standard response exists; each is answered as a custom response with a 4-day median turnaround.
Human-approved by Dr. Elena Moretti on 09 Sept 2026
Recurring MI question (14 in 60 days) on washout when switching from anti-CGRP mAbs; no standard response, driving custom-response workload and SLA pressure.
helixor-private-llm-2026.08 · generated 08 Sept 2026, 09:12 UTC
AI summary
Cluster of 14 switching/washout inquiries; recommend standard response creation.
Source spans used by the model
Fourteen inquiries in the last 60 days ask whether a washout is needed when switching from an anti-CGRP monoclonal antibody to lumevarin. No standard response exists; each is answered as a custom response with a 4-day median turnaround.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Medical-information need | Medical-information need |
| Function | Medical Information | Medical Information |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 3 | 20% | 12.0 |
| Strategic alignment | 4 | 20% | 16.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 2 | 10% | 4.0 |
| Actionability | 5 | 10% | 10.0 |
| Confidence | 5 | 5% | 5.0 |
| Breadth of occurrence | 5 | 5% | 5.0 |
| Total | High 73 | ||
No audit events in sample data
Every model call on this record and its human outcome
| Time | Feature | Model | User | Confidence | Outcome |
|---|---|---|---|---|---|
| 08 Sept 2026, 09:12 UTC | Duplicate detection | helixor-embed-v2 | Fatima Al-Sayed | 94% | Accepted |
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
Insight
Reviewed 09 Sept 2026 by Dr. Elena Moretti
Medical Information · Fatima Al-Sayed · due 10 Oct 2026 · In progress
Medical-information improvement · Fatima Al-Sayed · At risk
Decision
Outcome
Content update · INI-0303
Closure